Biomarkers and New Drug Targets

Biomarker are defined as these are the biological characteristic that is objectively measured and they are evaluated as an indicator of the normal biological or the pathological processes, or a response to a therapeutic intervention. Biomarkers are also important in the development of the new drug therapies through the discovery of "druggable targets." In addition to the identifying of drug targets, the biomarkers have the potential to speed development of the new disease therapies through the use of "progression" markers to delineate the development and the course of a disease. Researchers can also use the changes in the progression markers to understand and how a new therapy is successfully slowing – or even reversing – the disease process. Results of the studies like these will allow researchers to focus on the efforts and resources on the most effective therapies, thus reducing the time and the cost to bring a new therapy to the market and eventually to the patient.

  • Biomarker and Drug Target Validation
  • Image Documentation and In Situ Visualization
  • Biomarker Assay Development

Related Conference of Biomarkers and New Drug Targets

January 29-30, 2026

19th World Drug Delivery Summit

Paris, France
February 10-11, 2026

40th World Congress on Pharmacology and Therapeutics

Barcelona, Spain
February 23-24, 2026

3rd World Congress on Biologics and Biosimilars

London, UK
March 23-24, 2026

36th Annual European Pharma Congress

London, UK
March 24-25, 2026

11th International Conference on Future Pharma and Innovations

Amsterdam, Netherlands
April 16-17, 2026

19th European Biosimilars Congress

Rome, Italy
April 27-28, 2026

9th European Biopharma Congress

Paris, Aland Islands
May 28-29, 2026

3rd International Conference on Pharmacognosy

Madrid, Spain
July 27-28, 2026

39th World Congress on Pharmacology

Rome, Italy
September 24-25, 2026

6th World Congress on Rare Diseases & Orphan Drugs

Paris, France

Biomarkers and New Drug Targets Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in